DarioHealth Corp Deferred Revenue Trend

DarioHealth Corp -- USA Stock  

USD 2.07  0.03  1.43%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2.3 M, Interest Expense of 2 M or Operating Expenses of 8.2 M, but also many exotic indicators such as Asset Turnover of 0.1247, Current Ratio of 2.11 or Free Cash Flow per Share of 0.43. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed Deferred Revenue of DarioHealth Corp with missing and latest data points interpolated. A component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue, including sales, license fees, and royalties, but excluding interest income.
Deferred Revenue  10 Years Trend  
Increasing
Slightly volatile
 Deferred Revenue 
      Timeline 

DarioHealth Corp Deferred Revenue Over Time

2015-12-31  31,000 
2016-12-31  31,000 
2017-12-31  36,471 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  31,456
Geometric Mean  31,423
Coefficient Of Variation  5.02
Mean Deviation  835.78
Median  31,000
Standard Deviation  1,579
Sample Variance  2,493,945
Range  5,471
R Value  0.48
Mean Square Error  2,110,261
R Squared  0.23
Significance  0.11
Slope  210.41
Total Sum of Squares  27,433,391

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14